For more on the individual components, see: What Is BPC-157
Several landmark cardiovascular outcome trials have demonstrated that GLP-1RAs can significantly reduce the risk of major adverse cardiovascular events (MACE), which include cardiovascular death, nonfatal myocardial infarction (heart attack), and nonfatal stroke [43]
Gastrointestinal Problems Some people have reported nausea, bloating, and abdominal pain after taking huge doses of glutathione
Valavanidis, A., Vlachogianni, T
BPC-157, in particular, has been the focus of research involving tissue regeneration and angiogenesis - both essential for supporting recovery in strained or damaged areas